New episode of Sandoz TV available

May 15, 2012 - Sandoz has just launched its ninth episode of Sandoz TV.

Sandoz testimony at FDA hearing on biosimilars will emphasize need for consistent regulatory standards across all biologics

Holzkirchen, Germany, May 09, 2012 - Sandoz announced today that Dr. Mark McCamish, Head of Global Biopharmaceutical Development, will present on behalf of the Novartis Group of companies (Novartis) at the May 11 Food and Drug Administration (FDA) public hearing on draft guidances related to the development of biosimilar products.

Sandoz to acquire Fougera Pharmaceuticals, becoming the number one generic dermatology medicines company globally and in the US

Basel, Switzerland, May 02, 2012 - Definitive agreement to acquire Fougera Pharmaceuticals for USD 1.525 billion in an all-cash transaction

Novartis announces Q1 2012 results

Basel, April 24, 2012 - Pharmaceuticals and Alcon performed strongly in the first quarter; overall Group results impacted by expected challenges